This period is marked by intense diplomatic activity aimed at unblocking negotiations on the pandemic agreement. Following the decision to extend talks (The Economic Times), an open letter from the Director-General of the World Health Organization (WHO) and the Brazilian President calls on leaders of the G7, G20 and BRICS to finalize the annex on pathogen benefit-sharing (PBS), setting new discussions for 6 to 17 July (WHO). Meanwhile, a significant rapprochement is taking place between the United States and Gavi, the Vaccine Alliance (GAVI), welcomed by the WHO (Macau Business) and opening the way to a possible restoration of American funding of 600 million dollars for antimalarial vaccines (Pakistan Today). Finally, the WHO has issued an alert on the expansion of dengue, which now threatens more than half of the global population (WHO), while targeted efforts continue at the national level, as illustrated by Pakistan's commitment with the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) to combat HIV (24 News HD).

Pandemic agreement negotiations: new diplomatic momentum to finalize the PBS component

Following the decision by World Health Organization (WHO) member states on 19 May 2026 to extend negotiations on the future pandemic agreement (The Economic Times), health diplomacy experienced a notable acceleration. On 15 June 2026, in a joint open letter, the Director-General of the WHO, Dr Tedros Adhanom Ghebreyesus, and the President of Brazil, Luiz Inácio Lula da Silva, directly addressed the leaders of the G7, G20, BRICS and all nations. Their appeal emphasizes the urgency of finalizing the annex on Access to Pathogens and Benefit-Sharing (PBS), considered as the cornerstone of equity in preparedness and response to future health crises (WHO).

The letter recalls the devastating human and economic cost of the COVID-19 pandemic, with estimates reaching up to twenty million deaths and an economic impact of more than thirteen trillion dollars, according to the International Monetary Fund (IMF). This appeal highlights the main fault line in the negotiations: the balance between rapid access to pathogen samples by developed countries and pharmaceutical industries, and a fair and equitable sharing of benefits (vaccines, diagnostics, treatments) with developing countries where these pathogens are often identified. The (context) "zero draft" of 2023 proposed that the WHO receive 20% of pandemic products to ensure this equity (Health Policy Watch), a proposal that remains at the heart of the debates.

Implications: Brazil's involvement, which holds the G20 presidency, confers major political weight to this initiative. It aims to mobilize political will at the highest level to overcome blockages, particularly from countries hosting large pharmaceutical industries. The challenge is to transform an equity principle into an operational and binding mechanism. A new round of negotiations is already scheduled for 6 to 17 July 2026 to attempt to reach an agreement on this crucial annex (WHO). Failure of these talks risks perpetuating the inequalities observed during the COVID-19 crisis, undermining confidence in the multilateral health system.

Vaccination financing: warming of US-Gavi relations reshuffles the deck

The landscape of global vaccination financing experienced a major shift this month. In early June, reports indicated a willingness by the United States of America to re-engage with Gavi, the Vaccine Alliance (GAVI), in the context of an Ebola epidemic (Fine Day 102.3, 2 June). This signal, attributed to American Senator Rubio, was quickly and publicly welcomed by the Director-General of the WHO, Dr Tedros, on 4 June, who underlined the importance of this gesture for vaccine diplomacy (Macau Business).

This rapprochement is not merely diplomatic; it could have substantial financial consequences. According to press reports from 9 June, Gavi hopes to obtain the restoration of American funding in the amount of 600 million dollars, specifically intended to support the deployment of antimalarial vaccines (Pakistan Today). This prospect is crucial for Gavi, which recently unveiled (context: June 2024) an ambitious strategic plan for its next five-year period aimed at "protecting more children, against more diseases, faster than ever" (Gavi, the Vaccine Alliance).

Implications: American reinvestment would be a strong signal for all donors and would considerably strengthen Gavi's financial position. For the United States, it is a reaffirmation of its leadership in global health, potentially in response to the growing influence of other actors such as China. For beneficiary countries in Africa, Asia and Latin America, this would translate into better access to new-generation vaccines, such as those against malaria, and would strengthen the resilience of health systems to epidemics, as Gavi recalled in an opinion piece on Ebola on 12 June (Gavi, the Vaccine Alliance). The challenge will be to translate this political announcement into firm budgetary commitments in the American Congress.

Alert signals and field responses: dengue expansion and targeted pandemic response

Beyond governance structures, the period was marked by health alerts and concrete field actions.

  • Dengue alert: On 15 June, Dr Tedros described dengue as a threat that is "no longer sporadic and confined to the tropics," emphasizing that more than half of the global population now lives in at-risk areas (WHO). He called for coordinated action including surveillance, innovative vector control strategies and equitable access to vaccines and care. This alert highlights the impact of climate change on the geographic expansion of vector-borne diseases, constituting a major trend for global health security.

  • Response to Ebola in Uganda: In the context of an active epidemic, the Director-General of the WHO participated in a briefing for the diplomatic corps in Kampala on 9 June (Tedros WHO). Organized by the Ministry of Health of Uganda (MoHUG), the event aimed to share the latest information on the epidemic response. Dr Tedros firmly supported the call for "solidarity and cooperation," and the application of evidence-based health measures, while speaking out against travel and trade bans, which are often counterproductive.

  • Partnership against HIV in Pakistan: On 9 June, Pakistani Prime Minister Shehbaz Sharif welcomed his country's partnership with the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). He announced the creation of a joint working group to strengthen the fight against HIV, in response to an increase in infections in the country (24 News HD). This initiative illustrates the Global Fund's operational model, which relies on national partnerships to tailor responses to local contexts, a key issue as the organization recently formalized a strategic framework with UNAIDS to end AIDS (Global Fund).

Photo: Salya T / Unsplash